Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
03/06/2008 | WO2008026564A1 Urea derivative |
03/06/2008 | US20080058529 Method for the preparation of oxazoles by condensing aromatic aldehydes with alpha-ketoximes to form n-oxides and reacting same with activatived acid derivatives |
03/06/2008 | US20080058387 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
03/06/2008 | US20080058213 Benzoxazole Compounds |
03/05/2008 | EP1893590A1 Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors |
03/05/2008 | EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists |
03/05/2008 | EP1893582A2 Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
03/05/2008 | EP1893573A1 Inhibitors of hcv replication |
03/05/2008 | EP1893571A2 Process for production of 4-biphenylyazetidin-2-ones |
03/05/2008 | CN101137660A Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
03/05/2008 | CN101137627A Process for the preparation of substituted benzoxazole compounds |
03/05/2008 | CN101137626A Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
03/04/2008 | US7339003 Antioxidants and antioxidant boosters capable of producing hydroperoxyl radicals |
03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
03/04/2008 | US7338956 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
02/28/2008 | WO2008024892A2 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
02/28/2008 | US20080051583 Novel intermediate compounds useful in the production of diarylcycloalkyl derivatives |
02/28/2008 | US20080051446 Heterocyclocarboxamide Derivatives |
02/28/2008 | US20080051418 Arylalkanoic Acid Derivative |
02/28/2008 | CA2661401A1 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors |
02/28/2008 | CA2660524A1 Compounds for treating proliferative disorders |
02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
02/27/2008 | CN101133030A Menthane carboxamide derivatives having cooling properties |
02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
02/26/2008 | US7335674 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
02/26/2008 | US7335671 containing a 2-(hetero)aryloxazol-4-ylalkylcycloalkyl group, (2R/2S)-3-[(1R,3S)-3-(5-methyl-2-m-tolyloxazol-4-ylmethoxymethyl)-cyclohexyloxy ]-2-(4-trifluoromethylbenzyloxy)propionic acid; treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization and insulin resistance; |
02/26/2008 | CA2322195C Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
02/21/2008 | WO2008020270A1 Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
02/21/2008 | WO2008006043A3 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents |
02/21/2008 | WO2007103456A3 Piperazine and piperidine biaryl derivatives |
02/21/2008 | US20080045720 Reacting a naphthalenecarboxylic acid halide compound with ammonium acetate in a solvent such as tetrahydrofuran; high yield and at low cost; as chemical intermediates in producing dyes such as azo dyes, medical and agricultural chemicals |
02/21/2008 | US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
02/21/2008 | CA2660814A1 Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
02/21/2008 | CA2659208A1 Oxazolidone derivatives as pr modulators |
02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
02/20/2008 | EP1888727A1 New dha derivatives and their use as medicaments |
02/20/2008 | EP1888532A1 Heteroaroyl-substituted serine amides |
02/20/2008 | EP1888512A2 Chemical compounds |
02/20/2008 | CN101128443A Process for the purification of substituted benzoxazole compounds |
02/20/2008 | CN101128442A Processes for the preparation of linezolid intermediate |
02/20/2008 | CN101125833A Optically active bisoxazoline compounds, process for production of the same and use thereof |
02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
02/20/2008 | CN100369909C N-[4(R)-(1,3-dioxane)methyl] aniline and its prepn and use |
02/20/2008 | CN100369903C Five-membered-ring compound |
02/19/2008 | US7332611 N-thiolated 2 oxazolidone antibiotics |
02/19/2008 | US7332518 Carboxamides as fungicides in agriculture |
02/19/2008 | US7332516 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
02/19/2008 | US7332515 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
02/19/2008 | US7332500 Heterocyclic antiviral compounds |
02/19/2008 | US7332485 Peptide deformylase inhibitors |
02/19/2008 | US7332105 Stabilizer mixture comprising specific compounds of the 2,4-bis-(4-phenylphenyl)-6-(2-hydroxyphenyl)-1,3,5-triazine class and selected other UV absorbers as protectants against damage by light, heat and oxygen |
02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
02/14/2008 | WO2008017827A2 Azole and thiazole derivatives and their uses |
02/14/2008 | WO2008017816A2 Chemical compounds |
02/14/2008 | WO2008002570A3 Human protein tyrosine phosphatase inhibitors and methods of use |
02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
02/13/2008 | EP1887005A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
02/13/2008 | EP1885704A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof |
02/13/2008 | EP1885703A2 Processes for production of phenolic 4-biphenylylazetidin-2-ones |
02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
02/12/2008 | US7329770 Esters as useful broad spectrum herbicidal compounds |
02/12/2008 | US7329682 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative |
02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
02/12/2008 | US7329318 Methods of crystal precipitation |
02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
02/12/2008 | CA2197467C Method for the preparation of taxol and its derivatives |
02/07/2008 | WO2007142904A3 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands |
02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
02/06/2008 | CN101119979A Crystalline forms of linezolid intermediate |
02/06/2008 | CN101119722A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
02/06/2008 | CN100366617C Benzoxazole azo-compound for generating carrier |
02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
02/05/2008 | US7326790 Diphenylisoxazole compounds and hydro isomers thereof |
02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
02/05/2008 | US7326695 Anti-bacterial agents based upon oxoanion binding |
02/05/2008 | CA2395204C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
01/31/2008 | WO2007149395A3 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer |
01/31/2008 | WO2007119106A3 Processes for preparing intermediate compounds useful for the preparation of ezetimibe |
01/31/2008 | US20080027228 Substituted thioacetamides |
01/31/2008 | US20080027211 Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments |
01/31/2008 | US20080027053 Antimicrobial oxazolidinone prodrugs |
01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
01/31/2008 | US20080026067 Method for Increasing Specific Surface Area of Slightly Soluble Drug |
01/31/2008 | DE102006034256A1 Verbesserung der Bioverfügbarkeit von Wirkstoffen mit Amidinfunktion in Arzneimitteln Improve the bioavailability of drugs with amidine in drugs |
01/31/2008 | CA2657247A1 Compounds which modulate the cb2 receptor |
01/30/2008 | CN101115721A Indenyl derivatives and use thereof for the treatment of neurological disorders |
01/30/2008 | CN101115717A Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
01/30/2008 | CN100364981C Chiral dibenz [a,c] suberyl diallyl double oxazoline ligand compound and its preparation and application |
01/29/2008 | US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of |
01/29/2008 | US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient |
01/29/2008 | CA2215682C 10-deacetylbaccatine iii and 10-deacetyl 14.beta.-hydroxybaccatine iii derivatives, a process for the preparation thereof and pharmaceutical compositions containing them |